Zimmer Biomet Holdings PE Ratio 2012-2025 | ZBH
Current and historical p/e ratio for Zimmer Biomet Holdings (ZBH) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zimmer Biomet Holdings PE ratio as of January 23, 2026 is 10.82.
| Zimmer Biomet Holdings PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-23 | 86.60 | 21.44 | |
| 2025-09-30 | 98.24 | $4.04 | 24.32 |
| 2025-06-30 | 90.75 | $4.11 | 22.08 |
| 2025-03-31 | 112.31 | $4.52 | 24.85 |
| 2024-12-31 | 104.60 | $4.45 | 23.50 |
| 2024-09-30 | 106.65 | $5.26 | 20.28 |
| 2024-06-30 | 106.99 | $4.80 | 22.29 |
| 2024-03-31 | 129.82 | $4.62 | 28.10 |
| 2023-12-31 | 119.48 | $4.89 | 24.43 |
| 2023-09-30 | 109.96 | $2.26 | 48.65 |
| 2023-06-30 | 142.35 | $2.41 | 59.07 |
| 2023-03-31 | 126.11 | $2.14 | 58.93 |
| 2022-12-31 | 124.21 | $1.10 | 112.92 |
| 2022-09-30 | 101.66 | $1.32 | 77.02 |
| 2022-06-30 | 101.93 | $1.09 | 93.51 |
| 2022-03-31 | 123.81 | $1.03 | 120.20 |
| 2021-12-31 | 119.07 | $1.90 | 62.67 |
| 2021-09-30 | 136.92 | $3.89 | 35.20 |
| 2021-06-30 | 150.21 | $4.36 | 34.45 |
| 2021-03-31 | 149.30 | $2.69 | 55.50 |
| 2020-12-31 | 143.50 | $-0.71 | 0.00 |
| 2020-09-30 | 126.58 | $-0.76 | 0.00 |
| 2020-06-30 | 110.78 | $0.16 | 692.37 |
| 2020-03-31 | 93.62 | $1.81 | 51.72 |
| 2019-12-31 | 138.29 | $5.47 | 25.28 |
| 2019-09-30 | 126.62 | $-0.49 | 0.00 |
| 2019-06-30 | 108.41 | $-1.78 | 0.00 |
| 2019-03-31 | 117.34 | $-1.53 | 0.00 |
| 2018-12-31 | 95.12 | $-1.88 | 0.00 |
| 2018-09-30 | 120.29 | $8.70 | 13.83 |
| 2018-06-30 | 101.77 | $8.39 | 12.13 |
| 2018-03-31 | 99.37 | $8.39 | 11.84 |
| 2017-12-31 | 109.72 | $9.01 | 12.18 |
| 2017-09-30 | 106.25 | $3.18 | 33.41 |
| 2017-06-30 | 116.27 | $3.48 | 33.41 |
| 2017-03-31 | 110.37 | $2.42 | 45.61 |
| 2016-12-31 | 93.09 | $1.47 | 63.33 |
| 2016-09-30 | 117.01 | $1.28 | 91.42 |
| 2016-06-30 | 108.13 | $0.61 | 177.26 |
| 2016-03-31 | 95.58 | $-0.14 | 0.00 |
| 2015-12-31 | 91.75 | $0.36 | 254.86 |
| 2015-09-30 | 83.82 | $1.13 | 74.18 |
| 2015-06-30 | 97.25 | $1.98 | 49.12 |
| 2015-03-31 | 104.43 | $3.92 | 26.64 |
| 2014-12-31 | 100.60 | $4.19 | 24.01 |
| 2014-09-30 | 89.01 | $4.64 | 19.18 |
| 2014-06-30 | 91.74 | $4.58 | 20.03 |
| 2014-03-31 | 83.37 | $4.44 | 18.78 |
| 2013-12-31 | 81.95 | $4.43 | 18.50 |
| 2013-09-30 | 72.08 | $3.95 | 18.25 |
| 2013-06-30 | 65.60 | $4.07 | 16.12 |
| 2013-03-31 | 65.67 | $4.40 | 14.93 |
| 2012-12-31 | 58.04 | $4.29 | 13.53 |
| 2012-09-30 | 58.72 | $4.28 | 13.72 |
| 2012-06-30 | 55.74 | $4.27 | 13.05 |
| 2012-03-31 | 55.51 | $4.11 | 13.51 |
| 2011-12-31 | 46.00 | $4.02 | 11.44 |
| 2011-09-30 | 46.05 | $3.33 | 13.83 |
| 2011-06-30 | 54.42 | $3.28 | 16.59 |
| 2011-03-31 | 52.12 | $3.04 | 17.15 |
| 2010-12-31 | 46.22 | $2.97 | 15.56 |
| 2010-09-30 | 45.06 | $3.53 | 12.76 |
| 2010-06-30 | 46.54 | $3.27 | 14.23 |
| 2010-03-31 | 50.98 | $3.43 | 14.86 |
| 2009-12-31 | 50.90 | $3.33 | 15.28 |
| 2009-09-30 | 46.02 | $3.34 | 13.78 |
| 2009-06-30 | 36.68 | $3.59 | 10.22 |
| 2009-03-31 | 31.43 | $3.60 | 8.73 |
| 2008-12-31 | 34.81 | $3.71 | 9.38 |
| 2008-09-30 | 55.59 | $4.08 | 13.63 |
| 2008-06-30 | 58.60 | $3.32 | 17.65 |
| 2008-03-31 | 67.04 | $3.30 | 20.32 |
| 2007-12-31 | 56.96 | $3.26 | 17.47 |
| 2007-09-30 | 69.74 | $3.16 | 22.07 |
| 2007-06-30 | 73.10 | $3.73 | 19.60 |
| 2007-03-31 | 73.55 | $3.57 | 20.60 |
| 2006-12-31 | 67.49 | $3.41 | 19.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $17.349B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $188.859B | 21.09 |
| EssilorLuxottica (ESLOY) | France | $145.490B | 0.00 |
| Stryker (SYK) | United States | $137.164B | 27.23 |
| Boston Scientific (BSX) | United States | $135.332B | 30.95 |
| Medtronic (MDT) | Ireland | $129.919B | 18.00 |
| Medline (MDLN) | United States | $60.378B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.195B | 0.00 |
| Agilent Technologies (A) | United States | $39.301B | 24.84 |
| GE HealthCare Technologies (GEHC) | United States | $37.303B | 17.84 |
| ResMed (RMD) | United States | $37.266B | 25.79 |
| Koninklijke Philips (PHG) | Netherlands | $28.637B | 18.70 |
| Terumo (TRUMY) | Japan | $20.358B | 22.92 |
| Insulet (PODD) | United States | $19.697B | 61.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.055B | 0.00 |
| Baxter (BAX) | United States | $10.317B | 8.33 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.233B | 29.60 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.455B | 13.57 |
| BillionToOne (BLLN) | United States | $4.145B | 0.00 |
| Envista Holdings (NVST) | United States | $4.014B | 23.03 |
| ICU Medical (ICUI) | United States | $3.914B | 24.85 |
| Haemonetics (HAE) | United States | $3.278B | 14.59 |
| Prestige Consumer Healthcare (PBH) | United States | $3.257B | 14.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Neogen (NEOG) | United States | $2.159B | 47.26 |
| QuidelOrtho (QDEL) | United States | $2.076B | 13.35 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $1.990B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.945B | 39.15 |
| Curaleaf Holdings (CURLF) | Canada | $1.764B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.687B | 16.85 |
| Green Thumb Industries (GTBIF) | United States | $1.649B | 72.27 |
| Kestra Medical Technologies (KMTS) | United States | $1.442B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.422B | 20.59 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.390B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.251B | 371.14 |
| Capricor Therapeutics (CAPR) | United States | $1.105B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.064B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.890B | 10.06 |
| Valneva SE (VALN) | France | $0.886B | 0.00 |
| Omeros (OMER) | United States | $0.861B | 0.00 |
| CeriBell (CBLL) | United States | $0.842B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.602B | 16.32 |
| Verano Holdings (VRNO) | United States | $0.516B | 0.00 |
| Cerus (CERS) | United States | $0.503B | 0.00 |
| Brainsway (BWAY) | Israel | $0.474B | 80.63 |
| Canopy Growth (CGC) | Canada | $0.431B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.426B | 0.00 |
| Quanterix (QTRX) | United States | $0.337B | 0.00 |
| Evolus (EOLS) | United States | $0.329B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.282B | 22.51 |
| TriSalus Life Sciences (TLSI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.245B | 144.33 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.235B | 0.00 |
| High Tide (HITI) | Canada | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.199B | 17.54 |
| Sanara MedTech (SMTI) | United States | $0.198B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.195B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.183B | 0.00 |
| Accendra Health (ACH) | United States | $0.163B | 1.64 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.56 |
| Sharps Technology (STSS) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.23 |
| Nephros (NEPH) | United States | $0.050B | 35.85 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Bonk (BNKK) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.27 |
| Jin Medical (ZJYL) | China | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |